BNTC8:00 AMBenitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal StudyPresentation / Abstract • Phase 1ESGCT late-breaking poster presentation Tue, Oct 27, 2026benitec.com
BNTC4:00 PMBenitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational UpdatePresentation / Abstract • Phase 1/2ESGCT presentation Tue, Oct 27, 2026benitec.com